Bausch Health Says Board Authorized Management To Explore Potential Sale Of Subsidiary Bausch + Lomb; Says Process Is Ongoing. No Decision Has Been Reached
Bausch Health Says Board Authorized Management To Explore Potential Sale Of Subsidiary Bausch + Lomb; Says Process Is Ongoing. No Decision Has Been Reached
The company issued the following statement in response to a request from the Canadian Investment Regulatory Organization (CIRO):
公司就加拿大投资监管机构（CIRO）的请求发布了以下声明：
"As previously disclosed, the Company believes that completing the full separation of its subsidiary, Bausch + Lomb, makes strategic sense. The Bausch Health Board of Directors authorized management and management of its subsidiary, Bausch + Lomb, to explore a potential sale, which is one of several options being considered to complete the separation. That process is ongoing. No decision has been reached to proceed with any particular transaction, and there can be no assurance that it will result in a transaction."
"正如之前披露的，公司相信完整分离其子公司Bausch + Lomb是具有战略意义的。Bausch Health董事会授权管理层及其子公司Bausch + Lomb的管理层探索潜在的出售，这是完成分离的几个期权之一。该过程正在进行中。尚未达成推进任何特定交易的决定，因此无法保证会导致任何交易的达成。"